Mibavademab
R4461-MOB-2471
Phase 3 small_molecule active
Quick answer
Mibavademab for Monogenic Obesity is a Phase 3 program (small_molecule) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Monogenic Obesity
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active